Digital Pharma

2018年9月19-20日 • 新加坡, One Farrer Hotel & Spa

概要

數位革命在許多不同的產業領域中造成了破壞性的變化,製藥業界也不例外。Digital Pharma Summit將針對全球製藥業界的技術面展望、新趨勢、革新導入策略、投資、數位化計畫個案研究等各種主題展開討論。

本高峰會是IBC主辦第5屆PharmaCon Asia 2018活動的其中一環,是亞洲地區製藥業界相關從業專職人員齊聚一堂的重要活動。臨床試驗、市場參與、製藥業界數位化、法令遵守原則等主題都將在會議期間被提出討論,聚焦於藥物開發及商業化相關價值鏈的各個領域。

活動焦點

  • 亞洲地區唯一以製藥業界數位化為主題的活動,將介紹各種企業受到數位轉換影響的個案研究。
  • 與亞洲及世界各地數位轉換專家建立人脈,了解其對於製藥業界的看法。
  • 了解技術面的展望及對製藥業界的影響。
  • 聚焦於技術面的最新趨勢與數位技術的進步。
  • 製藥業界生態系統中新的商業模型與革新合作的相關分析。
  • 介紹在數位化層面受到矚目的製藥公司最新情報。

同時舉行的活動

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Summit >>
Pharma Market Access and Pricing Summit Asia >>

 

議程

8:00 am

Registration and Networking Session

PHARMACON ASIA OPENING PLENARY SESSION

9:00 am

Addressing on skilled talent, strong manufacturing capabilities and thriving research ecosystem in pharmaceutical firms to set up to serve patients and connect with the growing Asian market

9:30 am

[Industry Address] Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines

Nik Leist, Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

10:40 am

Morning Networking and Refreshment Break

DIGITAL PHARMA SUMMIT COMMENCES

11:10 am

Digital Pharma Chairman's Opening Remarks

TRENDS IN DIGITALISATION

11:15 am

CIO Interview: Progressing Digital Transformation in Pharma

Bruce Shi, Chief Information Officer, Asia, Sanofi, Singapore

11:45 am

  • Snapshots on tech trends that are gaining traction
  • Where are digital investments going?
  • How can pharmaceutical companies leverage them in compliance with stringent regulations
  • New regulatory framework to build trusted algorithms

CIO Interview: Progressing Digital Transformation in Pharma

Bruce Shi, Chief Information Officer, Asia, Sanofi, Singapore

REDEFINING PHARMA - CONSUMER INTERACTIONS

1:00 pm

Networking Lunch

2:00 pm

  • Importance of staying engaged with consumers/patients
  • Preparing for disruption
  • Why MNCs are at risk of disruptions

2:30 pm

Developing Innovative Technological Solutions to Improve Patient Outcomes

Aaron Tian, Head of Neuroscience Patient Innovation, UCB, China

3:00 pm

Tech Showcase: Strategies to Seamlessly Integrated and Personalised Customer Experience and Patients Outcomes Online and Offline

3:30 pm

Afternoon Networking

4:00 pm

  • How can digitalisation and connected world play the part in monitoring better patient outcomes, drug performance and market dynamics of approved drugs?
  • How is the deployment of smartphone seen as 'an access to global knowledge powered by AI in anyone's hand'
  • How can it trigger a revolution in pharmacovigilance and risk minimisation?
  • Case studies to elaborate on the need for a versatile app to enforce educational risk minimization

4:30 pm

  • The rise of apps as medical devices
  • The convergence between tech and pharma
  • How artificial intelligence will make healthcare more efficient

REGIONAL TRENDS IN PHARMA 4.0

5:00 pm

  • 100 Experiments (100E) programme
  • How the Pharma industry is benefiting
  • Use cases of how AI is applied in the Pharma industry

5:30 pm

  • Examining the current impact of digitalisation in the Asian Pharma sector
  • What touch points will have most influence
  • How is Pharma – HCP - Patient engagement going to change
  • Pharma and Consumer interface evolution
  • What is needed to give Pharma a digital boost

6:00 pm

End of Conference Day 1, followed by networking cocktails

8:55 am

Morning Coffee

PHARMA - HCP RELATIONSHIPS

9:00 am

Digitalising Pharma - HCP Engagement: Challenges, Opportunities and Benefits

Julie Olszewski, Executive Director, MSD Global Innovation Hub, MSD, Singapore

9:30 am

  • Patient journey and their experience with medication is changing with the increasing pervasiveness of digital and mobile communication platform
  • Addressing technological advancement such as cloud, IoT, data analytics and AI
  • Medical doctors' experience on rapid change and transformation from the impact of technology
  • How can patients, doctors and pharma find the convergence and success in digital solutions and what good (experience) looks like?

BEYOND THE PILL

10:00 am

Digital Pharma and Precision Medicine in the Age of Data Science, Machine Learning and Real Time Analytics

Yaron Turpaz, Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

10:30 am

Morning Networking and Refreshment Break

11:00 am

  • Trends of digital innovations in Pharma & Healthcare
  • Challenges in adapting digitalization in these fields
  • How digitalization will help to create value chain for the patients

11:30 am

Use & Perception of Scientific Medical Reprints and Opportunities in Digital Marketing

Amit Singh, Director - Pharma Business, Elsevier, India

12:00 pm

  • Overview of emerging trends in medical technologies, and extrapolation to future business opportunities for digital pharma
  • Direct-to-consumer distribution and supply chain optimisation

12:30 pm

Networking Lunch

1:30 pm

Case Study: Preventing the Risk of Cardiovascular Disease via a Doctor - Patient - Consumer Digital Platform

Dr. Peter Ting, Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, Singapore

2:00 pm

The Impact of Technology in Reshaping the Thinking of Pharma Leaders - Transformation, Investments, Business Strategies

Tamsin Greulich-Smith, Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of Singapore, Singapore

ENABLING DIGITALISATION

2:30 pm

  • Starting out on analytics journeys - common starting points that set you up for failure
  • Problems with process - 'right governance wrong place' processes that set analytics up to fail
  • Metric malfunction - how managing an analytics department can look right on paper but still be worthless
  • 3 big ideas that will help you avoid these pitfalls and get real value from analytics

3:00 pm

  • Will this be a barrier for pharma companies to digitally transform?
  • How can traditional practices be seamlessly transform to accommodate to the digital age's needs?

3:30 pm

Afternoon Networking

CLOSING PLENARY SESSION

5:00 pm

Chairperson's Summary of the Day and End of Conference

* 活動內容有可能不事先告知作更動及調整。

演講者

Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Nik Leist

Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Angel Rivera Tapia

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei

Country President, AstraZeneca, Singapore

Bruce Shi

Chief Information Officer, Asia, Sanofi, Singapore

Amkidit Afable

Director Go-To-Market, Johnson & Johnson, Singapore

Aaron Tian

Head of Neuroscience Patient Innovation, UCB, China

Jean-Christophe Delumeau

Head of Pharmacovigilance Policy Strategy, Bayer, Singapore

Laurence Liew

Director, AI Singapore, Singapore

Prabhuram Krishnan

Medical Director (South Asia - Hong Kong, ASEAN, India), Ipsen, Singapore

Rafiqul Islam

IT Head-ADC Asia Pac, IT Business Relationship, Abbott Laboratories, Singapore

Jason Tamara Widjaja

Associate Director, Global Data Science (AI & Data Products), MSD, Singapore

Julie Olszewski

Executive Director, MSD Global Innovation Hub, MSD, Singapore

Paul Tan

Director, KPMG Healthcare & Life Sciences, Singapore

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

Mrunalini Jagtap

Data Management Lead, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore

Amit Singh

Director - Pharma Business, Elsevier, India

Dr. Dinesh Visva Gunaskeran

Steering Committee (Head, Big Data Protocol), Collaborative Ocular Tuberculosis Study, Singapore

Dr. Peter Ting

Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, Singapore

Tamsin Greulich-Smith

Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of Singapore, Singapore

Winston Chew

Director, Regional Information Security Officer, GlaxoSmithKline, Singapore

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

日程和地點

2018年9月19-20日

新加坡, One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

免費電子郵件通知服務